Evolent Health (EVH) Market Capitalization (2015 - 2026)

Evolent Health has reported Market Capitalization for 12 years, with the latest figure at $612.8 million in Q2 2026.

• On a quarterly basis, Market Capitalization fell 53.69% year-over-year to $612.8 million in Q2 2026; TTM through Jun 2026 was $612.8 million, a 53.69% decrease from a year earlier, with the FY2025 full-year figure at $446.6 million, down 65.95% from the prior year.
• Market Capitalization was $612.8 million for Q2 2026 at Evolent Health, up from $256.5 million in the prior quarter.
• The five-year high for Market Capitalization was $3.8 billion in Q4 2023, with the low at $256.5 million in Q1 2026.
• Average Market Capitalization over 5 years is $2.3 billion, with a median of $2.9 billion recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Market Capitalization jumped 68.48% in 2022, then sank 76.93% in 2026.
• Over 5 years, Market Capitalization stood at $3.1 billion in 2022, then rose by 22.27% to $3.8 billion in 2023, then tumbled by 65.6% to $1.3 billion in 2024, then plunged by 65.95% to $446.6 million in 2025, then surged by 37.22% to $612.8 million in 2026.
• The last three Market Capitalization figures came in at $612.8 million (Q2 2026), $256.5 million (Q1 2026), and $446.6 million (Q4 2025), per Business Quant data.